Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001578563-25-000197

Chief Executive Officer gave up 17,787 shares (to pay taxes)

  • Chief Executive Officer acquired 64,867 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
NEIL GARRY ARTHUR Chief Executive Officer 2025-03-28 Option exercise +64,867 64,927 D: show line 1 in the form
NEIL GARRY ARTHUR Chief Executive Officer 2025-03-28 Shares withheld for taxes −17,787 $8.46 $150,478 47,140 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
NEIL GARRY ARTHUR Chief Executive Officer 2025-03-28 Option exercise · Restricted Stock Units +64,867 129,733 D: show line 3 in the form
Loading xslF345X05/primary_doc.xml…